[Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease]
[Article in
Italian]
- PMID: 5428170
Item in Clipboard
[Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease]
[Article in
Italian]
Minerva Med.
.
No abstract available
Similar articles
-
Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.Trans Am Neurol Assoc. 1969;94:85-90. Trans Am Neurol Assoc. 1969. PMID: 4907453 Clinical Trial. No abstract available.
-
L-Dopa therapy in Parkinson's disease.J Fla Med Assoc. 1970 Jun;57(6):23-7. J Fla Med Assoc. 1970. PMID: 4392779 No abstract available.
-
[The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].Riv Neurobiol. 1970 Jul-Sep;16(3):247-54. Riv Neurobiol. 1970. PMID: 5518838 Italian. No abstract available.
-
Parkinson's disease; modern treatment.Minn Med. 1973 Jun;56(6):497-502. Minn Med. 1973. PMID: 4575903 Review. No abstract available.
-
[Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].Shinkei Kenkyu No Shimpo. 1971;15(4):992-1002. Shinkei Kenkyu No Shimpo. 1971. PMID: 4400830 Review. Japanese. No abstract available.
Cited by
-
Clinical pharmacokinetics of amantadine hydrochloride.Clin Pharmacokinet. 1988 Jan;14(1):35-51. doi: 10.2165/00003088-198814010-00003. Clin Pharmacokinet. 1988. PMID: 3280212 Review.